Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
about
The PICALM protein plays a key role in iron homeostasis and cell proliferationPolyphenol Stilbenes: Molecular Mechanisms of Defence against Oxidative Stress and Aging-Related DiseasesImaging multiple sclerosis and other neurodegenerative diseasesMitochondrial iron-sulfur cluster dysfunction in neurodegenerative diseaseAlzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: maintenance of brain iron homeostasisMorphological and bioenergetic demands underlying the mitophagy in post-mitotic neurons: the pink-parkin pathwayA Bacterial Component to Alzheimer’s-Type Dementia Seen via a Systems Biology Approach that Links Iron Dysregulation and Inflammagen Shedding to DiseaseFe²⁺ block and permeation of CaV3.1 (α1G) T-type calcium channels: candidate mechanism for non-transferrin-mediated Fe²⁺ influx.Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.Iron metabolism disturbance in a French cohort of ALS patientsThe potential for transition metal-mediated neurodegeneration in amyotrophic lateral sclerosisGene co-expression networks shed light into diseases of brain iron accumulation.Association studies of MMP-9 in Parkinson's disease and amyotrophic lateral sclerosis.Programmed cell death in aging.Impaired iron status in aging researchIron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons.Linking restless legs syndrome with Parkinson's disease: clinical, imaging and genetic evidence.Significant glial alterations in response to iron loading in a novel organotypic hippocampal slice culture model.Meta-analysis of brain iron levels of Parkinson's disease patients determined by postmortem and MRI measurements.Gene expression analysis reveals the dysregulation of immune and metabolic pathways in Alzheimer's disease.Astrocyte hepcidin is a key factor in LPS-induced neuronal apoptosis.Does any drug to treat cancer target mTOR and iron hemostasis in neurodegenerative disorders?Shared mechanisms of neurodegeneration in Alzheimer's disease and Parkinson's disease.Mice Overexpressing Both Non-Mutated Human SOD1 and Mutated SOD1(G93A) Genes: A Competent Experimental Model for Studying Iron Metabolism in Amyotrophic Lateral Sclerosis.Hepcidin Plays a Key Role in 6-OHDA Induced Iron Overload and Apoptotic Cell Death in a Cell Culture Model of Parkinson's Disease.Longitudinal assessment of metal concentrations and copper isotope ratios in the G93A SOD1 mouse model of amyotrophic lateral sclerosis.A Novel Iron Chelator-Radical Scavenger Ameliorates Motor Dysfunction and Improves Life Span and Mitochondrial Biogenesis in SOD1G93A ALS Mice.TDP-43 modification in the hSOD1(G93A) amyotrophic lateral sclerosis mouse model.A Potential Biomarker in Amyotrophic Lateral Sclerosis: Can Assessment of Brain Iron Deposition with SWI and Corticospinal Tract Degeneration with DTI Help?Significance and In Vivo Detection of Iron-Laden Microglia in White Matter Multiple Sclerosis Lesions.Redox metals homeostasis in multiple sclerosis and amyotrophic lateral sclerosis: a review.Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.No effects without causes: the Iron Dysregulation and Dormant Microbes hypothesis for chronic, inflammatory diseases.Neuroimaging of Sleep Disturbances in Movement DisordersSerum ferritin is a candidate biomarker of disease aggravation in amyotrophic lateral sclerosis
P2860
Q24298166-092A9320-1F4B-48BA-B4CC-84E9E55BA91CQ26800956-10DD48E2-8FA4-405C-AA16-D2C3F46D33B0Q26826889-436C19A6-45A0-47AD-BE0B-48895411E59EQ27015737-E12B1019-FFA0-40ED-9C56-8CC9557E6B83Q27024824-F963A66A-C3CC-4BBE-A3B4-E526B24904A5Q28396161-E0E63D0A-A52D-4D52-909C-645FC7A7C0F5Q29248210-ABB8CD1F-411D-4CA4-B86E-C179D36CBA03Q30416140-9033450A-9B54-425A-8996-7DDE86C307BCQ30837513-518E3034-D890-4D7E-9169-4B3BBAFE7350Q33914518-D35A82FE-4853-40C8-96CC-18F76A084580Q33938412-FC69C47B-BCF7-4F5E-B77A-88AEC8672EF4Q34506653-3FB2C454-06D8-4669-B150-E9683034722DQ34989297-904DC6D7-14D7-47C8-91D7-3630FBAF97F0Q35779447-D89C948F-35DC-4899-B232-B9A87BE23FDFQ35795910-626039DF-A0CE-4309-804F-D53EA446AA2CQ35867096-1389ABAB-099E-4A82-B73C-3CBE22E3021AQ36444445-25E4BEDA-DAFB-4D48-B29C-ECCEDED4EA5AQ37390184-13DEEB72-A700-45D5-BFB8-AEDFA05E1BFCQ37402514-9998A550-E219-4E7D-A9F2-0D2A8A24F215Q37687240-CEE7B425-9710-47C4-8DE1-73D96435A0AFQ37745611-6DB344BB-93F7-4F9B-B471-C9EA45C34257Q39010650-780D8927-D187-4C45-A389-7DCEF2CD3AB3Q40017984-1358571D-6776-4201-B1BB-5EE4597569E2Q42673211-F68D809A-E40B-4225-AB6E-9341129A8750Q42745591-A9196E83-4D92-467A-B232-D79173EC1ED2Q48366167-5BC8B8A3-3F88-4FBC-B836-F33C7403FCC2Q48435698-AC64FA92-197E-407F-BD84-97A0E89AB55DQ48548755-7C8D0AFE-F47F-4397-9BC4-7303142DC5DDQ52147637-57E4B10B-4FE1-4B01-8852-44A97B6D2447Q52668328-7FC80F43-EE26-4144-A6B2-7756D0A5577AQ52678256-5B4ED856-EB5B-422C-A125-846339B5AD55Q52679530-3A083EF4-D57F-4EC7-950A-AA5CDDE5C497Q53698735-609A8D24-6A0F-42C5-9FE4-C45DBE42DBFFQ57493665-6DFB1DE4-5964-46ED-B06A-319EFD6E8D09Q58802718-009A1B62-B5BE-462C-A85A-BF17D7C9F654
P2860
Dysregulation of iron metabolism in Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis.
@en
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis.
@nl
type
label
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis.
@en
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis.
@nl
prefLabel
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis.
@en
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis.
@nl
P2860
P921
P356
P1476
Dysregulation of iron metaboli ...... amyotrophic lateral sclerosis
@en
P2093
Masataka Kikuchi
Satoru Oshiro
P2860
P304
P356
10.1155/2011/378278
P577
2011-10-12T00:00:00Z